DOCSLIB.ORG

Dehydroepiandrosterone Supplementation Improves Ovarian Reserve and Pregnancy Rates in Poor Responders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dehydroepiandrosterone Supplementation Improves Ovarian Reserve and Pregnancy Rates in Poor Responders European Review for Medical and Pharmacological Sciences 2020; 24: 9104-9111 Dehydroepiandrosterone supplementation improves ovarian reserve and pregnancy rates in poor responders M.D. OZCIL Department of Obstetrics and Gynecology, Mustafa Kemal University School of Medicine, Hatay, Turkey Abstract. – OBJECTIVE: We investigated Introduction whether DHEA supplementation had an impact on ovarian reserve parameters and pregnancy A trend for postponement of pregnancy due rates in patients with poor ovarian response to marriage at an older age has increased the ra- (POR) and primary ovarian insufficiency (POI). PATIENTS AND METHODS: A total of 34 tios of infertile couples in society. The decrease people, 6 patients with POI and 28 patients with in ovarian reserve with advancing age has led to POR, were included in the study. The patients new approaches in the treatment of infertile pa- in the POR group consisted of two different tients. The main causes of premature ovarian ag- groups: diminished ovarian reserve (DOR) and ing and diminished ovarian reserves are; endo- premature ovarian failure (PMOF). Patients in metriosis, genetics, stress, obesity, past mumps the POI and POR group were given 50 mg DHEA infection, chemotherapy, radiotherapy, smoking, supplementation daily for 5 months. The prima- ry outcome was to determine spontaneous clini- alcohol use, pesticides, chemical toxins, auto- cal pregnancy rates. The monthly changes in the immune diseases, idiopathic, ovarian induction serum hormone levels and AFC were recorded agents, systemic diseases, long-term analog or for five months. AMH levels were also measured antagonist use and diabetes mellitus. Many treat- before and after treatment. ment modalities have been attempted to improve RESULTS: The total follow-up time was 152 the reduced ovarian reserve. Dehydroepiandros- cycles. The number of pregnancies during the follow-up period was 9. The ratio of pregnan- terone (DHEA) has been used in approximately cies to the number of patients was 26.5% and 25% of in vitro fertilization (IVF) centers for the the rate per cycle was 5.9%. While 8 of 9 preg- treatment of infertile patients with poor ovarian nancies resulted in a live birth, one resulted in response (POR)1. a miscarriage. The rate of abortion was 11.1%. DHEA is naturally found in the Jerusalem ar- The mean AFC was 0 to 5 before treatment. tichoke, and in the human body is secreted by the Following DHEA administration, a significant adrenal gland (zona reticularis) and from the the- increase was detected in 30.8% of the patients. There was an increase in AMH levels after ca interna cells of the ovaries. DHEA has a role DHEA, but this was not significant. The live as precursor hormone in the synthesis of estra- birth rate and pregnancy rate per cycle were diol and testosterone2. It has a weak androgenic significantly higher in POR patients than those effect. After peaking between the ages of 20 and in POF. Patients with POF had no pregnancy. 30, DHEA levels decrease by about 2% each year Although the PMOF patients were younger than down to 10-20% of the peak at around the age of the DOR patients, the rate of pregnancy (36% 3 vs. 29%), and pregnancy rates per cycle (8.5% 80 years . The purpose of DHEA supplementa- vs. 6.35%) were higher in the DOR group. The tion is to replace DHEA in patients with reduced rates of live birth were the same in the PMOF ovarian reserves. The substitution of DHEA may and DOR groups (29% vs. 29%). correct the substrate pool of steroidogenesis. An- CONCLUSIONS: Oral DHEA supplementation drogens have been shown to increase steroidogen- improves both ovarian reserve and pregnancy esis and insulin-like growth factor 1 (IGF-1) in rates in women with POR. primate ovaries4,5. IGF-1 levels in preantral and early antral follicles have been reported to be ele- Key Words: vated in DHEA-treated mouse ovaries6. Casson et DHEA, POR, POI, Ovarian reserve, Pregnancy 7 rates. al reported that DHEA supplementation was use- ful in intrauterine insemination (IUI) treatment 9104 Corresponding Author: Mustafa D. Ozcil, MD; e-mail: [email protected] Dehydroepiandrosterone supplementation improves ovarian reserve in patients with poor response to ovarian stimula- considered with the presence of a fetal heartbeat. tion. This benefit of DHEA is attributed to an in- Serum Follicle Stimulating Hormone (FSH), Lu- crease in serum-free IGF-I concentration, which teinizing Hormone (LH), and Estradiol (E2) levels in turn increases the gonadotropin response in the were measured at baseline and monthly during target organ7. In 2005, it was shown that oocyte 5 months after DHEA supplementation. Fast- production was increased, and 9 healthy embry- ing blood samples of the patients were collected os were obtained after DHEA supplementation in with venipuncture. All samples were centrifuged a 43-year-old IVF patient with DOR8. However, at 1500 g for 10 min, at 4°C. Serum FSH, LH, several studies have reported conflicting results E2 and progesterone levels were evaluated with of DHEA supplementation on ovarian reserve the electrochemiluminescence method (ADVIA markers and pregnancy outcomes in infertile pa- Centaur XP, Siemens Diagnostics, Los Angeles, tients with diminished ovarian reserve (DOR) or CA, USA). The AFC (2-10 mm follicles) as deter- premature ovarian failure (PMOF)9-15. The aim of mined by transvaginal ultrasonography (General this study was to investigate the effect of DHEA Electric RTX 200, Boston, MA, USA). supplementation on ovarian reserve parameters Patients were excluded if they had a history of and pregnancy rates in infertile patients with a malignant or borderline ovarian tumor, meta- POR or primary ovarian insufficiency (POI). bolic disease, a chromosomal disease in either of the partners, male factor infertility, or hysterosal- pingography revealing defective female genita- Patients and Methods lia. Genetic disorders such as Turner syndrome, patients using alkylating agents or radiotherapy, A total of 34 women, 6 patients with POI and patients who underwent ovarian surgery, patients 28 patients with POR, were included in the study. with hyper or hypothyroidism, patients with type The patients in the POR group consisted of two dif- I diabetes, those with Cushing disease or Addison ferent patient groups: diminished ovarian reserve disease, excessively obese cases and extremely (DOR) and premature ovarian failure (PMOF). weak cases were also not included in the study. Patients who met at least two of the Bologna cri- The study was approved by the Ethics Committee teria were accepted as poor ovarian reserve16-18. of Mustafa Kemal University School of Medicine These criteria were: (1) advanced maternal age (Protocol No: 2017/157-27.10.2017-183). Informed (≥40 years) or other risk factors for poor ovarian consent was obtained from all the patients. reserves; (2) history of previous POR (≤3 oocytes with conventional over stimulation protocols); and Statistical Analysis (3) an abnormal ovarian reserve test [i.e., an antral Statistical analyses were performed with the follicular count: AFC, < 5-7 follicles or < 0.5-1.1 SPSS 20.0 software (IBM Armonk, NY, USA). ng/ml of Anti-Mullerian Hormone (AMH)]. Se- Data were shown as mean ± standard deviation rum AMH levels were analyzed by using AMH (SD) values or percentage. The effect of DHEA on Gen II ELISA kit (Beckman-Coulter, Inc., Brea, ovarian reserve parameters was evaluated. Per- CA USA). Values are expressed in ng/mL. Prima- centages of serum hormone levels before and after ry ovarian insufficiency (POI, primary ovarian treatment were compared using the Paired t-test. failure, POF) was defined as a 4-month period of Percentages of AFC in the groups were compared amenorrhea, serum FSH levels > 40 IU/L at one- using the Chi-square test. The pregnancy outcome month intervals, and a decrease in sex steroids in was compared according to age, infertility status women younger than 40 years. Patients in the POI and the type of ovarian pathology. A p ˂0.05 was and POR group were given 50 mg DHEA (Inter- considered as statistically significant. pharm, Konya, Turkey) supplementation daily for 5 months. This time interval was chosen because of early follicular growth induced by DHEA oc- Results curs within et least 2 months of treatment. The primary outcome was to determine spontaneous The demographic and follow-up characteristic clinical pregnancy rates. Pregnancy was evalu- of 34 participants during DHEA supplementa- ated in all patients with serum β-HCG levels af- tion is summarized in Table I and Figure 1. The ter menstruation delay. Patients with a positive mean age of the patients was 35.8 ± 7.6 years. 24 β-HCG result underwent TV-USG at 6 weeks af- out of the 34 patients were primary infertile. The ter the last menstruation. Clinical pregnancy was remaining ten patients were secondary infertile. 9105 M.D. Ozcil Table I. General characteristics and pregnancy outcomes of patients with POR and POF given DHEA supplementation. Age (year, mean± SD) 35,8 ± 7.6 Infertility status Primary infertility (n, %) 24 (70.5%) Secondary infertility (n, %) 10 (29.5%) Type of ovarian dysfunction POF (n, %) 6 (17.6%) PMOF (n, %) 14 (41.1%) DOR (n, %) 14 (41.1%) Total follow up period (cycles, n) 152 Total number of pregnancies achieved and percent based on number of patients (n, %) 9 (26.4%) Total number of pregnancies achieved and percent based on number of cycles (n, %) 9 (5.9%) Total number of pregnancies delivered in term (n, %) 8 (23.5%) Total number of abortions (n, %) 1 (11.11%) POF: Primary Ovarian Failure; PMOF: Premature Ovarian Failure; DOR: Diminished Ovarian Reserve; SD: Standard Deviation; N: Patient number. The total follow-up time of patients was 152 cy- ber of mean AFCs ranged from 1 to 5. Following cles. The total number of pregnancies during the DHEA administration, a significant increase was follow-up period was 9.
Load more

Recommended publications
  • The Relationship Between H19 and Parameters of Ovarian Reserve Xi Xia1,2, Martina S
    Xia et al. Reproductive Biology and Endocrinology (2020) 18:46 https://doi.org/10.1186/s12958-020-00578-z RESEARCH Open Access The relationship between H19 and parameters of ovarian reserve Xi Xia1,2, Martina S. Burn2, Yong Chen3,2, Cengiz Karakaya4 and Amanda Kallen2* Abstract Context: The H19 long noncoding RNA (lncRNA) belongs to a highly conserved, imprinted gene cluster involved in embryonic development and growth control. We previously described a novel mechanism whereby the Anti- mullerian hormone (Amh) appears to be regulated by H19. However, the relationship between circulating H19 and markers of ovarian reserve including AMH not been investigated. Objective: To determine whether H19 expression is altered in women with decreased ovarian reserve. Design: Experimental study. Setting: Yale School of Medicine (New Haven, USA) and Gazi University School of Medicine (Ankara, Turkey). Patients or other participants: A total of 141 women undergoing infertility evaluation and treatment. Intervention: Collection of discarded blood samples and cumulus cells at the time of baseline infertility evaluation and transvaginal oocyte retrieval, respectively. Main outcome measure: Serum and cumulus cell H19 expression. Results: Women with diminished ovarian reserve (as determined by AMH) had significantly lower serum H19 expression levels as compared to controls (p < 0.01). Serum H19 was moderately positively correlated with serum AMH. H19 expression was increased 3.7-fold in cumulus cells of IVF patients who demonstrated a high response to gonadotropins, compared to low responders (p < 0.05). Conclusion: In this study, we show that downregulation of H19 in serum and cumulus cells is closely associated with decreased ovarian reserve, as measured by decreased AMH levels and reduced oocyte yield at oocyte retrieval.
    [Show full text]
  • Endometriosis, Ovarian Reserve and Live Birth Rate Following in Vitro
    THIEME 218 Original Article Endometriosis, Ovarian Reserve and Live Birth Rate Following In Vitro Fertilization/ Intracytoplasmic Sperm Injection Endometriose, reserva ovariana e taxa de nascidos vivos após FIV/ICSI Marcela Alencar Coelho Neto1 Wellington de Paula Martins1 Caroline Mantovani da Luz1 Bruna Talita Gazeto Melo Jianini1 Rui Alberto Ferriani1 Paula Andrea Navarro1 1 Department of Obstetrics and Gynecology, Faculdade de Medicina Address for correspondence Paula Andrea Navarro, MD, PhD, de Ribeirão Preto, Universidade de São Paulo – USP, Ribeirão Preto, Departmento de Ginecologia e Obstetrícia, Faculdade de Medicina de SP, Brasil Ribeirão Preto, Hospital das Clínicas de Ribeirão Preto, Centro de Reprodução Humana, Universidade de São Paulo, Avenida Rev Bras Ginecol Obstet 2016;38:218–224. Bandeirantes, 3.900, 8o andar, Ribeirão Preto, caixa postal: 14048- 900, Ribeirão Preto, SP, Brazil (e-mail: [email protected]). Abstract Purpose To evaluate whether women with endometriosis have different ovarian reserves and reproductive outcomes when compared with women without this diagnosis undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ ICSI), and to compare the reproductive outcomes between women with and without the diagnosis considering the ovarian reserve assessed by antral follicle count (AFC). Methods This retrospective cohort study evaluated all women who underwent IVF/ ICSI in a university hospital in Brazil between January 2011 and December 2012. All patients were followed up until a negative pregnancy test or until the end of the pregnancy. The primary outcomes assessed were number of retrieved oocytes and live birth. Women were divided into two groups according to the diagnosis of endometri- osis, and each group was divided again into a group that had AFC 6 (poor ovarian reserve) and another that had AFC 7 (normal ovarian reserve).
    [Show full text]
  • Unexplained Infertility
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, University of Helsinki, Finland UNEXPLAINED INFERTILITY Studies on aetiology, treatment options and obstetric outcome RITA ISAKSSON ACADEMIC DISSERTATION To be presented by permission of the Medical Faculty of the University of Helsinki for public criticism in the Auditorium of the Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Haartmaninkatu 2, Helsinki, on October 18th, 2002, at 12 noon. Helsinki 2002 1 Supervised by Docent Aila Tiitinen, M.D., Ph.D. Department of Obstetrics and Gynaecology Helsinki University Central Hospital Docent Bruno Cacciatore, M.D., Ph.D. Department of Obstetrics and Gynaecology Helsinki University Central Hospital Reviewed by Docent Anne-Maria Suikkari, M.D., Ph.D. The Family Federation of Finland, Infertility Clinic, Helsinki Docent Aydin Tekay, M.D., Ph.D. Department of Obstetrics and Gynaecology Oulu University Central Hospital Offi cial opponent Docent Hannu Martikainen, M.D., Ph.D. Department of Obstetrics and Gynaecology Oulu University Central Hospital ISBN 952-91-5071-7 (print) ISBN 952-10-0712-5 (PDF) Yliopistopaino Helsinki 2002 2 To my family 3 CONTENTS LIST OF ORIGINAL PUBLICATIONS ....................................................................7 ABBREVIATIONS .................................................................................................
    [Show full text]
  • Age and Fertility: a Guide for Patients
    Age and Fertility A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications Committee. No portion herein may be reproduced in any form without written permission. This booklet is in no way intended to replace, dictate or fully define evaluation and treatment by a qualified physician. It is intended solely as an aid for patients seeking general information on issues in reproductive medicine. Copyright © 2012 by the American Society for Reproductive Medicine AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Age and Fertility A Guide for Patients Revised 2012 A glossary of italicized words is located at the end of this booklet. INTRODUCTION Fertility changes with age. Both males and females become fertile in their teens following puberty. For girls, the beginning of their reproductive years is marked by the onset of ovulation and menstruation. It is commonly understood that after menopause women are no longer able to become pregnant. Generally, reproductive potential decreases as women get older, and fertility can be expected to end 5 to 10 years before menopause. In today’s society, age-related infertility is becoming more common because, for a variety of reasons, many women wait until their 30s to begin their families. Even though women today are healthier and taking better care of themselves than ever before, improved health in later life does not offset the natural age-related decline in fertility. It is important to understand that fertility declines as a woman ages due to the normal age- related decrease in the number of eggs that remain in her ovaries.
    [Show full text]
  • Endometrioma Is a Responsible Factor for Reduced Ovarian Reserve
    Bangladesh J Obstet Gynaecol, 2015; Vol. 30(2): 98-104 Endometrioma is a Responsible Factor for Reduced Ovarian Reserve MOSAMMAT RASHIDA BEGUM1, MARIYA EHSAN2, NAZIA EHSAN3, FARHANA SHARMIN4, FARZANA KHAN5, AURIN IFTEKAR AMIN6 Abstract: Objective (s): The aim of the study was to assess ovarian reserve (OR) of patients with endometrioma and to explore the differences of ovarian reserve in age matched group of infertile patients without endometrioma. Materials and methods: This prospective analytic study was done in Infertility Care and Research Center, between January 2013 and December 2015 to assess the ovarian reserve of patients with endometrioma. During this period 105 patients of endometriosis with endometrioma were selected for study. Selection criteria were: no history of previous surgery, <36 years of age, no history of endocrine problems, no history of recent medical treatment for this condition within 6 months and no history of irregular menstruation. For ovarian reserve testing we assessed serum FSH, E2 and AMH. Patient of same age group who had no emdometrioma, no history of any surgery, no menstrual irregularity, endocrine disorder or any other medical diseases were taken as control to compare the ovarian reserve between these two groups. For control group also we did the same tests. Data was analyzed by SPSS package. One-way ANOVA test was done for test of significance. A p-value of <0.05 was considered as significant. Results: There was no difference in characteristics of patients of both groups regarding age, type of infertility and duration of infertility. Size of the endometriotic cysts were variable and average diameter of cyst was 6.2 ±2.32 cm.
    [Show full text]
  • Yamamoto Capstone Page 1 of 117 Comparing
    Yamamoto Capstone Comparing the Effects of TCM Therapy Durations on Pregnancy Outcome of Infertile Advanced Maternal Aged Women A Capstone Project Submitted in partial fulfillment of the requirements for the Doctor of Acupuncture and Oriental Medicine Degree By Kumiko Yamamoto L.Ac., Dipl. OM. Yo San University Los Angeles, California April 2013 Page 1 of 117 2 . Approval Signature Page This Capstone Project has been reviewed and approved by: Lawrence J. Ryan, PhD., Capstone Advisor June 10, 2013 Daoshing Ni, PhD., L.Ac. Specialty Chair June 10, 2013 Andrea Murchison, DAOM, L.Ac. June 10, 2013 Yamamoto Capstone ABSTRACT Fertility declines with age, and age is one of the most important factors that affect female fertility. There is an increasing population of advanced maternal aged (AMA) women with infertility, however, their treatment options are often limited, and prognoses are poor. Traditional Chinese Medicine (TCM) has been utilized as a complementary and alternative medicine modality for treating infertility. The goal of this study was to investigate the effects of TCM treatment durations (less than 3 months vs. more than 3 months) on the pregnancy outcome (yes or no) of AMA women with infertility. A retrospective chart review of more than 500 charts using purposive, convenience sampling was engaged, and 67 eligible charts were reviewed. The results revealed that there was no significant difference between the two TCM treatment durations. From the findings of the current study, it is reasonable to state that AMA patients are likely to respond to TCM therapy within the first 3 months of treatments. Although not statistically significant, this trend from the current study implies that the 3-month period may be considered as an appropriate treatment cycle for TCM therapy when treating AMA patients with infertility.
    [Show full text]
  • Ovarian Reserve Assessment in Women with Different Stages of Pelvic Endometriosis
    PRACE ORYGINALNE Ginekol Pol. 2014, 85, 446-450 ginekologia Ovarian reserve assessment in women with different stages of pelvic endometriosis Ocena rezerwy jajnikowej u kobiet z endometriozą miednicy mniejszej Ewa Posadzka, Robert Jach, Kazimierz Pityński, Agnieszka Nocuń Department of Gynecological Oncology, Jagiellonian University, Cracow,Poland Abstract Introduction: Endometriosis is defined as the appearance of ectopic endometrial cells outside the uterine cavity. Ectopic cells demonstrate functional similarity to eutopic cells, but structural and molecular differences are signifi­ cant and manifest themselves in gene expression of the metalloproteinase genes, integrin or the Bcl-2 gene. Pelvic pain remains to be the main symptom of the disease. Endometriosis may cause dysfunction of the reproductive system and lead to infertility. Pathogenesis o f infertility in endometriosis is based on its influence on the hormonal, biochemical and immunological changes in the eutopic endometrium, as well as structural damages of the ovaries and the fallopian tubes. Objectives: The aim of the study was to assess the ovarian reserve in patients with endometriosis. Material and methods: A total of 39 patients (aged 22-34 years) with different stages of endometrial changes were recruited for the study. The number of antral follicles was rated by vaginal ultrasonography and the level of FSH was measured between days 1-3 of the menstrual cycle. The stage of the disease was established after lapa­ roscopy with the rASRM scale. Results:No statistically significant correlation between the number of follicles(AFC), the level of FSH and the stage of endometriosis was found. Conclusions: Evaluation o f the number o f antral follicles and measurements of the FSH level do not allow to pre­ dict the ovarian reserve in women with endometriosis.
    [Show full text]
  • Assessment of Ovarian Reserve in Infertile Patients
    REVIEW ARTICLE Assessment of Ovarian Reserve in Infertile Patients *P Begum1, DR Shaha2, Mahbuba3, L Sanjowal4, R Barua5, KM Hassan6 ABSTRACT Reduced ovarian reserve is a condition characterized by a reduced competence of the ovary to produce oocyte due to advanced age or congenital, medical surgical and idiopathic causes. Age is considered to be the principal factor in determining the reduction of ovarian reserve, especially in woman over 40 years of age, but it's well known that a premature reduction of ovarian reserve can also occur in young patients. Management of patients with diminished ovarian reserve is challenging for fertility experts and frequently the only option to conceive is represented by assisted reproduction technologies. Here we reviewed the aetiology, presentation and diagnosis of reduced ovarian reserve in advanced and young aged women and recent advances in the management of infertility in these women. Key Words: Reduced ovarian reserve; Diminished ovarian reserve; Premature ovarian failure Introduction The reduced ovarian reserve is a condition of by the Childhood Cancer Survivor Study show that reduced ability of the ovary to produce oocytes due the 6.3% of women who received cure for cancer to advanced age or congenital, medical, surgical and suffered of acute ovarian failure9. In this manuscript idiopathic causes. This condition, also known as we reviewed the aetiology, presentation and diminished ovarian reserve (DOR) is often used to diagnosis of reduced ovarian reserve in advanced and characterize women at risk for poor performance young aged women and recent advances in the with assisted reproductive technologies (ART) due to management of infertility in these women.
    [Show full text]
  • Reproductive Outcomes in Women with Low Ovarian Reserve
    REPRODUCTIVE OUTCOMES IN WOMEN WITH LOW OVARIAN RESERVE By DR BALA MURUHAN KARUNAKARAN A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY Institute of Metabolism and Systems Research College of Medical and Dental Sciences University of Birmingham February 2019 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract The number of women with low ovarian reserve seeking fertility treatment is increasing, due to advancing maternal age at conception. Women with low ovarian reserve have a low IVF success rate. This thesis aims to increase our understanding of women with low ovarian reserve, their reproductive outcomes and their reproductive physiology. The evidence is synthesised using two systematic reviews, a prospective cohort study, a retrospective analysis of data and two qualitative studies. The main findings are: 1. Low ovarian reserve, quantified by AFC, AMH and FSH, is associated with low live birth rates and incidences of pregnancy loss after assisted reproduction. 2. There is inter-cycle variation in AFC, AMH and FSH in women. In this cohort, FSH and AFC appear to have a higher magnitude of variation in comparison to AMH.
    [Show full text]
  • AMH Has No Role in Predicting Oocyte Quality in Women With
    www.nature.com/scientificreports OPEN AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ ICSI cycles Xiuliang Dai1,5, Yufeng Wang1,5, Haiyan Yang1,5, Tingting Gao1, Chunmei Yu1, Fang Cao1, Xiyang Xia1, Jun Wu2*, Xianju Zhou3,4* & Li Chen1* It has been widely acknowledged that anti-Müllerian hormone (AMH) is a golden marker of ovarian reserve. Declined ovarian reserve (DOR), based on experience from reproductive-aged women, refers to both the quantitative and qualitative reduction in oocytes. This view is challenged by a recent study clearly showing that the quality of oocytes is similar in young women undergoing IVF cycles irrespective of the level of AMH. However, it remains elusive whether AMH indicates oocyte quality in women with advanced age (WAA). The aim of this study was to investigate this issue. In the present study, we retrospectively analysed the data generated from a total of 492 IVF/ICSI cycles (from January 2017 to July 2020), and these IVF/ICSI cycles contributed 292 embryo transfer (ET) cycles (from June 2017 to September 2019, data of day 3 ET were included for analysis) in our reproductive centre. Based on the level of AMH, all patients (= > 37 years old) were divided into 2 groups: the AMH high (H) group and the AMH low (L) group. The parameters of in vitro embryo development and clinical outcomes were compared between the two groups. The results showed that women in the L group experienced severe DOR, as demonstrated by a higher rate of primary diagnosis of DOR, lower antral follicle count (AFC), higher level of basal follicle stimulating hormone (FSH) and cancelation cycles, lower level of E2 production on the day of surge, and fewer oocytes and MII oocytes retrieved.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) Reproductive choices in women with poor ovarian reserve and recurrent miscarriages Musters, A.M. Publication date 2012 Link to publication Citation for published version (APA): Musters, A. M. (2012). Reproductive choices in women with poor ovarian reserve and recurrent miscarriages. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:02 Oct 2021 1 Introduction Introduction Chapter Worldwide, more and more women are having their first child later in life (Mathews and Hamilton, 2009). This delayed child bearing has major repercussions, because - as women get older- reproductive problems such as subfertility and miscarriages lay on 1 the lure (Wood, 1989, Brigham et al., 1999). In the Netherlands, delayed childbearing is evident, as the mean age of women who become mothers for the first time has increased over the last 17 years from 24.8 to 29.4 years.
    [Show full text]
  • Rich Plasma in Patients with Poor Ovarian Reserve Or Ovarian Insufficiency
    Open Access Review Article DOI: 10.7759/cureus.12037 A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet- Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency Soumya R. Panda 1 , Shikha Sachan 2 , Smrutismita Hota 3 1. Obstetrics and Gynaecology, All India Institute of Medical Sciences, Mangalagiri, Guntur, IND 2. Obstetrics and Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND 3. Radiodiagnosis and Imaging, All India Institute of Medical Sciences, Mangalagiri, Guntur, IND Corresponding author: Soumya R. Panda, [email protected] Abstract The emergence of autologous platelet-rich plasma (PRP) therapy reflects a break-through for infertile patients with premature ovarian failure. To study the efficacy of intra-ovarian infusion of autologous PRP on the improvement of ovarian reserve parameters and the subsequent artificial reproductive technique (ART) cycle outcomes in infertile women with poor ovarian reserve or premature ovarian insufficiency, a systematic search in electronic databases like Medline (through PubMed), Embase, Scopus, Web of Science, and Cochrane was done using relevant search terms. Except for case series, case reports, and review articles, all other types of studies, those evaluated for the effects of intra-ovarian infusion of PRP in subfertile women for decreased ovarian reserve (DOR) or premature ovarian insufficiency (POI) were included in our systematic review. The data were extracted from each eligible study and cross-checked by two authors. Intra- ovarian PRP infusion appears to be effective in ovarian rejuvenation, and the results of the subsequent intracytoplasmic sperm injection (ICSI) cycle are encouraging. PRP intervention was found to be beneficial in terms of an improvement in ovarian reserve parameters (increase in serum anti-mullerian hormone or antral follicle count or decrease in serum follicular stimulating hormone).
    [Show full text]